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Identification and Light-Dependent Translocation of a
Cone-Specific Antigen, Cone Arrestin, Recognized by
Monoclonal Antibody 7G6
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Jeanne M. Frederick,1 Peter R. MacLeish,4 and Wolfgang Baehr1,2,5
PURPOSE. To elucidate the antigen recognized by monoclonal
antibody (mAb) 7G6, a widely used cone-specific marker.
METHODS. 7G6 immunocytochemistry was performed on sec-
tions of human, primate, and bovine retina. The antigen was
immunoprecipitated from human retinal lysates and purified
with protein G. Edman degradation and liquid chromatography
of tryptic peptides combined with tandem mass spectrometry
(LC-MS/MS) identified the antigen.
RESULTS. Sequencing of peptides derived from the immunopre-
cipitated 7G6 antigen identified it as cone arrestin. The identity
was confirmed by Western blot analysis with recombinant
human cone arrestin and competition with the antibody in
immunocytochemistry. Subcellular localization of cone arrestin
in dark-adapted and bleached bovine retinas showed that cone
arrestin accumulated in cone outer segments of light-adapted
retina but was more concentrated in the inner segments of
dark-adapted retina. By expression of truncated human cone
arrestin mutants systematically deleting areas divergent from
bovine and primate cone arrestins, the epitope of 7G6 was
identified as a divergent loop exposed at the surface within the
N-domain of cone arrestin.
CONCLUSIONS. Several independent methods established that the
7G6 antigen is cone arrestin. The 7G6 epitope is contained in
a divergent loop, the sequence of which is conserved in bovine
and primates but not other vertebrate species consistent with
the specificity of the antibody. The light-dependent transloca-
tion of cone arrestin suggests a role in light–dark adaptation of
cones. Because of the location of its gene on the X-chromo-
some, cone arrestin is a candidate gene for X-linked cone
dystrophies. (Invest Ophthalmol Vis Sci. 2003;44:2858–2867)
DOI:10.1167/iovs.03-0072
The cone-specific monoclonal antibody (mAb) 7G6 hasbeen shown to recognize all cone subtypes in the adult
primate retina and the labeling for it has been observed
throughout the cytoplasm of the cones.1 The antibody 7G6 has
been used as a universal primate cone marker in normal and
degenerating retina in several subsequent publications.2,3 (A
teaching set on normal and diseased human retinas assembled
by Ann Milam displaying retina sections stained with mAb 7G6
is available at http://www.penneye.com/html/jeff_berger_
memorial.html.) The 7G6 antigen was recently shown to colo-
calize in the cone cytoplasm with an unidentified p45 protein
that appears to share an epitope with the transcription factor
NRL.4 During early primate development, some heterogeneity
in 7G6 labeling was observed. For example, a subset of blue
cones was delayed in their acquisition of 7G6 immunoreactiv-
ity, suggesting a delayed expression of the antigen, whereas
the onset of 7G6 immunoreactivity in red and green cones
preceded both the expression of cone opsins and the forma-
tion of synaptic contacts in the inner plexiform layer.1
To investigate the nature of the antigen and its gene more
closely, we first used Western blot analysis of human macula
components to determine the mobility of the antigen in SDS-
PAGE. We then purified the antigen, generated proteolytic
peptides and sequenced them by both Edman degradation and
liquid chromatography combined with mass spectrometry (LC-
MS/MS). Sequence analysis of multiple fragments showed un-
ambiguously that the 7G6 antigen is indistinguishable from
cone arrestin (cArr, or X-arrestin). (Zhang H, Cuenca N,
Church-Kopish J, Ivanova T, Frederick JM, MacLeish PR, Baehr
W, ARVO abstract 1414, 2002). Arrestins are a large gene
family involved in regulation of G-protein–coupled receptors
and G-protein–linked cascades. The cone’s visual cascade is
thought to function very similarly to that of rods, but is com-
posed of components encoded by distinct genes. Most of these
components have been cloned and characterized, including
cone pigments,5 cone transducin -subunit,6 cGMP PDE,7
and cyclic nucleotide gated channel (CNG3)8 and  subunit.9
Most regulatory components such as guanylate cyclase–activat-
ing protein (CGAP)-1,10 guanylate cyclase (GC)-1,11 RGS9-1,12
G-protein–coupled receptor kinase (GRK)-1,13 and recov-
erin14,15 are present in both rods and cones in mammals.
Exceptions are the arrestins, which occur in cell-specific iso-
forms.
One hallmark of arrestin function is its relocalization in the
rod cell in a light-dependent manner. In dark-adapted retina,
arrestin is located in the inner segment, but redistributes rap-
idly to the outer segment on illumination.16,17 Recently, cone
arrestin was shown to translocate in the mouse retina, depend-
ing on illumination.18 We found that bovine cone arrestin
redistributes similarly in light- and dark-adapted bovine retina.
In the light, cone arrestin accumulates in the cone outer seg-
ments, presumably interacting with bleached cone visual pig-
ments and quenching the cone cascade. In contrast, in the
dark, cone arrestin accumulates in the inner segment. The
light-dependent translocation of cone arrestin depending on
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light history, similar to that of rod arrestin, suggests a novel
mechanism of light–dark adaptation in cones.
MATERIALS AND METHODS
Immunoprecipitation and Peptide Sequencing
Retinal extracts were prepared from human macular buttons obtained
from the Lions Eye Bank at the University of Utah 4 to 8 hours after
death. A crude extract of human maculae was mixed with 7G6 anti-
body and protein-G–coupled agarose (Santa Cruz Biotechnology, Santa
Cruz, CA) in IP buffer (20 mM Tris [pH 7.5], 150 mM NaCl, and 0.1%
Tween 20). The mixture was incubated 2 hours at room temperature
on a rocking platform. The agarose beads were pelleted by brief
centrifugation and washed three times with IP buffer. SDS (2 gel
loading buffer (45 L) was added to the agarose beads followed by
boiling for 2 minutes to elute the bound proteins completely. The
proteins were fractionated by 10% SDS-PAGE gel and stained with
Coomassie blue dye. Stained bands corresponding to the antigen were
excised from SDS-PAGE gel and submerged into destaining solution
(0.2 M NH4HCO3 containing 30% acetonitrile). After incubation at
30°C for 1 hour, the liquid was removed, and the fresh destaining
solution was added. The process was repeated until the gels were
completely destained. The gels were then fully dehydrated in a con-
centrator (SpeedVac; Thermo Savant, Holbrook, NY). For in-gel diges-
tion, the dried gels were rehydrated with 40 L 0.2 M NH4HCO3
containing 0.4 g sequencing-grade trypsin (Promega Corp., Madison,
WI). The proteolysis was stopped by adding 1/10 volume of 10%
trifluoroacetic acid (TFA). The released peptides were extracted sev-
eral times from the gel with 100 L of 0.1% TFA and 60% acetonitrile
followed by concentration (Speed-Vac; Thermo Savant) concentration.
The mixed peptides were submitted to the peptide-sequencing core
facility in University of Utah for separation by HPLC and sequencing by
Edman degradation. Meanwhile, the peptide mixture prepared under
the same conditions was submitted to the mass spectrometer core
facility (University of Utah) and analyzed by LC/MS-MS. The tryptic
peptides were loaded onto an HPLC system linked to a mass spectrom-
eter (LCQ Deca; Thermo Finnigan, San Jose, CA). The peptides were
eluted into the mass spectrometer and MS/MS spectra were generated.
The spectra were subjected to search against the databases on com-
puter with a commercially available program (Sequest Software, Lisle,
IL) to find the matched peptides. The retrieved peptide sequences
were compared with the sequences in GenBank (http://www.ncbi.
nlm.nih.gov/Genbank; provided in the public domain by the National
Center for Biotechnology Information, Bethesda, MD).
Western Blot Analysis
Human maculae were isolated from freshly obtained retinas using a
trephine (6 mm diameter). Two maculae were dropped into a micro-
centrifuge tube and homogenized with a plastic pestle in 100 L
hypotonic buffer A (20 mM Tris, [pH 8.0], 1 mM EDTA, 1 mM dithio-
threitol [DTT], and 100 M phenylmethylsulfonyl fluoride [PMSF]).
The tissue lysate was centrifuged at 600g for 5 minutes at 4°C. The
supernatant was removed and saved, and the pellet was homogenized
again in buffer A and recentrifuged as before. The supernatants from
these two centrifugations were combined and subjected to ultracen-
trifugation at 250,000g for 1 hour at 4°C. One tenth of the supernatant
and the entire pellet from ultracentrifugation were subjected to 10%
SDS-PAGE gel electrophoresis, and the resolved polypeptides were
transferred to a nitrocellulose filter (Bio-Rad, Hercules, CA). The filter
was probed with mAb 7G6 (1:150) followed by horseradish peroxidase
[HRP]-conjugated secondary antibody. The signal was visualized using
phosphorescence (ECL system; NEN Life Science, Boston, MA) and
detected by x-ray film.
Immunocytochemisty and Preabsorption Assay
Monkey eyes were obtained from the Texas Primate Center (Alice, TX)
and fixed as described previously.19 Adult human and bovine eyes
were dissected to remove the anterior segment, and the eye cup was
transferred to freshly prepared 4% paraformaldehyde in 0.1 M phos-
phate buffer (pH 7.4). After fixation for 2 hours at room temperature,
the eye cup was immersed in 10% sucrose in 0.1 M phosphate (1 hour),
20% sucrose in 0.1 M phosphate (1 hour), and 30% sucrose in 0.1 M
phosphate buffer (overnight). A small piece of retina-RPE was isolated
with a razor blade, embedded in commercial medium (TBS; Triangle
Biomedical Sciences, Durham, NC) and frozen. Sections (12-m thick)
were cut with a cryostat and mounted on gelatin-coated or charged
slides (Superfrost/Plus, Fisher Scientific, Pittsburgh, PA). Bovine sec-
tions from light- and dark-adapted specimens were mounted pair-wise
so that tissues from both were incubated in the same pool of antibody
solution. This facilitated direct comparison of 7G6 immunolocalization
correlating with light versus dark adaptation.
For immunocytochemistry, the sections were blocked with 0.1 M
phosphate buffer (pH 7.4), containing 1% BSA, 0.1% Triton X-100, and
10% normal goat serum, and probed by 7G6 antibody (1:100 or 1:200
dilution) followed by FITC-conjugated goat anti-mouse or TRITC-con-
jugated goat anti-mouse secondary antibody. For double labeling, the
sections were incubated simultaneously with mAb 7G6 and polyclonal
antibodies anti-calbindin (Swant, Bellinzona, Switzerland) overnight at
4°C. Sections were visualized by application of rhodamine (TRITC)-
conjugated goat anti-mouse and FITC-conjugated goat anti-rabbit sec-
ondary antibodies. The immunolocalization was imaged using a con-
focal microscope (model LSM 510; Carl Zeiss Meditech, Thornwood,
NY) set to an optical slit of 1 m.
A preabsorption study was performed to verify 7G6 antibody spec-
ificity. Fresh human retina was obtained from a 4-month-old infant
whose eye was enucleated because of retinoblastoma (biopsy tissue
provided by Nick Mamalis, University of Utah). The nontumorous
portion of the retina-RPE was dissected 2.5 hours after enucleation,
fixed for 2 hours in 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4), and cryoprotected in sucrose. Frozen sections were blocked
for 1 hour with 10% normal goat serum before incubation with mAb
7G6. As a negative control, 7G6 (1:200) was preabsorbed for 6 hours
with an excess amount of recombinant human cone arrestin (15 g
rCArrHis/50 L solution) before the solution was applied to the sec-
tions of retina. Immunoreactive sites were visualized by incubation 1
hour in FITC-conjugated goat anti-mouse IgG (1:300, cat. #115-095-
146; Jackson ImmunoResearch, West Grove, PA) as the secondary
antibody and imaged as described for immunocytochemistry.
Expression and Purification of Human
His-Tagged Cone Arrestin
The human His-tagged cone arrestin (hcArrHis) expression construct
was kindly provided by Cheryl Craft (University of Southern Califor-
nia). For this construct, full-length human cone arrestin cDNA was
cloned in frame into an expression vector (pTRC-His B; Promega). The
plasmid was transformed into Escherichia coli ER2556 (New England
Biolabs, Boston, MA), and a single colony was inoculated into 5 mL
Luria-Bertani (LB) medium and grown at 37°C. The overnight culture
was diluted into 100 mL of and continued growing to an OD600 of 0.6to
0.7. Isopropyl--D-1-thiogalactopyranoside (IPTG) was added to the
culture to a final concentration of 1 mM to induce the expression of
recombinant protein. After 5 hours of induction at 37°C, the culture
was harvested. The cells equal to 1.5 mL of culture were lysed with
lysozyme, and a fraction of the lysate was analyzed by Western blot
with 7G6 antibody. Recombinant hcArrHis was purified from 500 mL
of culture with a HisTrap column (Pharmacia/Amersham, Piscataway,
NJ) according to the manufacturer’s instructions. The purified protein
was verified by SDS-PAGE gel and quantified using a protein assay kit
(Cat. no. 500-0006; Bio-Rad).
Mutagenesis
To prepare human cone arrestin deletion mutants, mutagenesis was
performed with a kit (QuickChange; Stratagene, LaJolla, CA). Five
deletion mutants (see Fig. 4A) introducing stop codons after codons
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97, 168, 187, 343, and 355 were generated. Briefly, two complemen-
tary primers harboring a nonsense mutation in the center correspond-
ing to the desired stop position were synthesized (DNA synthesizer
model 392; Applied Biosystems, Foster City, CA). Simultaneously, a
silent restriction site (XbaI) was introduced into the primers to test the
newly generated plasmid DNAs for successful mutagenesis by XbaI
restriction digest. The primers were mixed with 50 ng of template
plasmid and recombinant Pfu polymerase, and the amplification was
performed for 16 cycles according to manufacturer’s instructions.
Methylated template DNA was removed by digestion with DpnI. A
small aliquot of the reaction mixture was used to transform E. coli.
The mutation was confirmed by DNA sequencing (Prism capillary
sequencer; Applied Biosystems). The IPTG-induced expression, purifi-
cation of the truncated proteins and Western blot were performed, as
described earlier.
Determination of Arrestin Gene Structures
Contigs from human (AL357752), mouse (AC091784), rat (AC095218),
and zebrafish (AL590151) were identified by screening the National
Center for Biotechnology Information (NCBI) high-throughput gene
sequences (htgs) using cone arrestin protein sequences and tblastn
(NCBI database). Gene structures were determined with cDNA or
protein sequences as templates. The novel zebrafish cArr gene struc-
ture was derived using 15 zebrafish cArr expressed sequence tags
(ESTs)—AW826248, AW826514, BE015717, BE015912, BE016049,
BF937662, BF937816, BF938932, BG305632, BG306321, BG306785,
BG306798, BI706094, BI879022, and BI879162—covering the entire
mRNA from the transcription start point to the poly(A) tail. Splice
variations were examined in all genes using partial cArr-specific ESTs.
Software for DNA analysis was Omiga 2.0 (Accelrys, Cambridge, UK;
available at http://www.accelrys.com/dstudio/ds_gene/) and DNA 
(DNAstar, Inc., Madison, WI; http://www.dnastar.com), both available
commercially.
Light and Dark Adaptation of Bovine Eyes
A pair of freshly enucleated bovine eyes was obtained from a local
abattoir. One eye was dark adapted for 3 hours on ice in a light-tight
metal can sealed with black tape and dissected in a darkroom under
dim red light. The retina-RPE was fixed in the dark with 4% parafor-
maldehyde solution. The other eye, placed on ice, was kept at room
light with an intensity of approximately 500 lux (normal room light).
The eye was dissected in normal room light, and the retina-RPE was
fixed in 4% paraformaldehyde and processed for immunocytochemis-
try, as described earlier.
RESULTS
Specificity of mAb 7G6
We first explored the cell specificity of the mAb 7G6 in human,
bovine, and primate retina (Fig. 1). Staining human frozen
sections with 7G6 (Fig. 1B) reveals expression of the antigen
exclusively in cones, apparently distributed throughout the
cell including cone pedicles, somata, and inner and outer
segments. Human retina incubated with a polyclonal anti-cal-
bindin antibody (Fig. 1A) reveals labeling in the cytoplasm of
the long-wavelength (LW) cone inner segments, the cell bod-
ies, and the synaptic pedicles. Staining in the outer segments
with this antibody is relatively weak. Note that short-wave-
length (SW) cones are only very faintly labeled with anti-
calbindin. The identity of these cones as SW cones was re-
cently confirmed by double labeling with anti-blue opsin
antibody.20 Anti-calbindin also labeled bipolar cells which are
7G6 immunonegative (results not shown). The function of
calbindin, an EF hand containing small Ca2 binding protein
with widespread distribution in neurons, is unknown, but it
has been suggested that it transports intracellular Ca2 and
protects against Ca2 mediated apoptosis.21 When human ret-
ina sections were double labeled with anti-calbindin and 7G6
(Fig. 1C), synaptic pedicles and inner segments of LW cones,
but not SW cones, showed colocalization. Apart from human
(Figs. 1B, 1C) and monkey (Fig. 1E) retinas, only bovine cones
were found to be immunopositive with mAb 7G6 (Fig. 1D).
Labeling of other vertebrate retinas (mouse, ground squirrel,
salamander) with 7G6 was unsuccessful (results not shown),
indicating that the 7G6 epitope is only present in primate and
bovine antigens. The results are consistent with mAb 7G6
recognizing an antigen present nearly exclusively in the cyto-
plasm of primate and bovine cone photoreceptors. Uniform
labeling with 7G6 and variation in double labeling with anti-
calbindin suggests that the 7G6 antigen is present in all cone
subtypes.
Identification of the 7G6 Antigen
To identify the 7G6 antigen in cones, we used Western blots
with macular extracts from human retina (the macula is rich in
cone photoreceptors). Western analysis revealed the presence
of the 7G6 antigen exclusively in the hypotonic supernatant,
and its absence in the membrane pellet (Fig. 2A). The apparent
mobility in denaturing SDS gels is approximately 44 to 46 kDa,
independent of denaturing the extract at high or low temper-
atures. To immunoprecipitate the 7G6 antigen, the hypotonic
macular extract was incubated with mAb 7G6 and protein-G–
coupled agarose.22 The immunoprecipitate was analyzed by
SDS-PAGE (Fig. 2B) revealing IgG (Fig. 2B, arrow 1) and the
7G6 antigen (Fig. 2B, arrow 2). We then determined proteo-
lytic peptide sequences of the immunoprecipitated 7G6 anti-
gen by two independent methods: Edman degradation and
LC-MS/MS. Edman degradation of a single proteolytic polypep-
tide yielded a sequence identical with a short fragment of
human cone arrestin (cArr) at positions 166-175 (Fig. 2C).
Separation of a mixture of proteolytic fragments by liquid
chromatography and subsequent mass spectrometric analysis
of individual peaks allowed identification of fragments cover-
ing essentially the entire cArr polypeptide, except for the
N-terminal region (Fig. 2C). The results show complete identity
of the 7G6 antigen with human cArr, a polypeptide of 388
amino acid residues. The calculated molecular mass of human
cArr is 43 kDa, consistent with the apparent mobility of the
7G6 antigen (44–48 kDa, Fig. 2A). In control experiments, we
expressed His-tagged human cArr in bacteria and analyzed the
recombinant protein by Western blot analysis (Fig. 2D). The
results show that the recombinant protein has an apparent
mobility of 50 kDa, slightly larger than the 7G6 antigen (the
recombinant protein carries a His tag), and is immunopositive
with mAb 7G6. When the mAb 7G6 is preabsorbed with
recombinant cArr, immunohistochemical labeling of cones
with 7G6 is completely abolished (Fig. 2E). These results es-
tablished unambiguously that the 7G6 antigen is cone arrestin.
Light-Dependent Redistribution of Cone Arrestin
The identification of the 7G6 antigen as cone arrestin raised the
interesting question of whether cone arrestins redistribute in
cones, as has been observed for rod arrestin (S-antigen) and
other phototransduction components (for review, see Ref. 23).
In dark-adapted mammalian retina, arrestin is located in the
inner segment, but moves rapidly to the outer segment, on
illumination. This apparent movement was controversial for
many years, but recently was shown to occur unambiguously
with rod T.24 Because dark-adapted primate retinas are very
difficult to obtain, we performed a series of experiments with
light- and dark-adapted bovine retinas, the only mammalian
species besides primates with 7G6 immunoreactivity (Fig. 1D).
In dark-adapted bovine retinas, cone arrestin distributes
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throughout the cytoplasm of cones, but accumulates predom-
inantly in the myoid region of cone inner segments (Fig. 3A),
the region where biosynthesis takes place. In the light, cone
arrestin accumulates strongly in the outer segments (Fig. 3B),
presumably interacting with bleached cone visual pigments
and inactivating the cone cGMP cascade. Accumulation of
these components in distinct compartments of photoreceptors
suggests the presence of a novel mechanism of photoreceptor
light- and dark-adaptation in both rod and cone photorecep-
tors.
Cone Arrestin Genes
To investigate potential links to human retina disease and the
diversity of cone arrestins, we next analyzed vertebrate cone
arrestin gene structures. The human and mouse cone arrestin
genes have been cloned, and their exon–intron arrangement
has been determined.25,26 These genes were shown to consist
of 17 exons (one noncoding exon is located in the 5untrans-
lated region [UTR]). We identified human (AC068231,
AL357752) and mouse (AC091784) genomic contigs in Gen-
Bank that verified the published gene structures (Figs. 4A, 4B).
The human contig AL357752 containing the entire cArr gene
localized the gene to chromosome X (q13.2-21.1) which sig-
nificantly narrowed the published locus (Xcen-Cq22).25 In ad-
dition to human and mouse, we determined the gene struc-
tures of rat (Rattus norvegicus) and zebrafish (Danio rerio)
cArr from large anonymous contigs (AC095218, AL590151)
containing the entire cArr genes. As expected, the rat cArr
gene structure (Fig. 4C), consisting of 17 exons, was nearly
identical with that of mouse and human (Figs. 4A, 4B). In
contrast, the zebrafish cArr gene (Fig. 4C) consisted of only 16
exons and encoded a 362 amino acid polypeptide with a
significantly truncated C-terminal region. The zebrafish cArr
gene features an exon 15 that is only 4 bp (one amino acid) in
length, separated from exons 14 and 16 by a 302 and 91 bp
introns, respectively. Like the mammalian cArr genes, the first
exon is located in the 5UTR. The predicted RNA and amino
acid sequences were verified by 15 independent ESTs (10 of
which are shown in Fig. 4D) that cover the entire 5UTR, the
coding sequence, and the 3UTR. In contrast to complex alter-
native splicing observed in human and mouse cArr genes,25,26
the zebrafish ESTs deposited in GenBank show no significant
FIGURE 1. Specificity of mAb 7G6 in
human, bovine, and monkey retina.
(A) Labeling of human cone photore-
ceptors with a commercially avail-
able polyclonal anti-calbindin anti-
body. Calbindin immunolocalization
is indicated by green labeling (FITC-
conjugated secondary antibody). The
brightly labeled cones are LW cones,
and the faintly labeled cones are SW
cones.20 Calbindin was present in
cone pedicles and the cytoplasm of
cone inner segments and at lower
levels in the outer segments. (B) La-
beling of human cone photorecep-
tors with 7G6 antibody visualized
with rhodamine-conjugated second-
ary antibody. Note uniform labeling
of LW and SW cones. (C) Double
labeling with anti-calbindin and 7G6
antibodies. Colocalization of calbin-
din and 7G6 antigen was strongest in
the inner segments and synaptic
pedicles of LW cones. (D) Bovine
sections of retina were labeled with
7G6 (red). As in humans, all of the
cone cells including synaptic
pedicles labeled with 7G6. (E) Ma-
caque retinas were labeled with
FITC-conjugated secondary antibody.
All retinas were fixed under normal
room light, and no precautions for
dark adaptation or complete bleach-
ing were taken.
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variation in splicing (apart from one EST with a short deletion
in the 3UTR). Phylogenetic analysis of the polypeptide se-
quences reveals that rod and cone arrestins fall into two dis-
tinct, but closely related subfamilies, as has been shown pre-
viously.27 The 7G6 epitope, however, is only present in
primate and bovine cone arrestins.
Functional and Divergent Domains in
Cone Arrestins
Vertebrate rod and cone arrestin amino acid sequences are
highly conserved (Fig. 5) suggesting that the overall three-
dimensional structure cone arrestin is very similar to that of rod
arrestin. The 0.28-nm crystal structure of rod arrestin showed
a bipartite molecule consisting of N- and C-domains.28 The
sequence similarity among rod arrestins is 51% to 83% (com-
pared with bovine arrestin), among cone arrestins 52% to 84%
(compared to bovine cone arrestins). Bovine arrestin is 47% to
55% similar to all cone arrestins shown in Figure 5. The arrestin
signature region (positions 57-75 in human cArr) is essentially
unaltered among all arrestins. Two N-linked glycosylation sites
(Fig. 5, gray boxes) are conserved in the rod and cone arrestins,
but N-glycosylation has not been established in arrestins (one
report29 suggested that a small population of rod arrestin may
be glycosylated). Among vertebrate cone arrestins, several re-
gions are divergent, the C-terminal region (last 30 residues) and
three relatively short regions of approximately 10 to 20 resi-
dues in the N-terminal half and the central part of the molecule
(Fig. 5, bars 1–4). Region 3 in cone arrestin is analogous to a
linker connecting two  sheets in the N- and C-domains of
arrestin, respectively. In rod arrestin, the C-terminal region is
important for locking arrestin into an inactive state.28 Se-
quence divergence in this region suggests flexibility in the
length to exert this important function.
The amino acid sequences in Figure 5 are from the follow-
ing sources: hum_cArr, accession no. 13633229 (National
Institutes of Health); bov_cArr, accession no. D8534036;
mus_cArr, accession no. NP_573468; rat cArr, derived from
contig AC095218; xen_cArr, accession P5148327; zebArr3
(Danio rerio), derived from a cDNA sequence extracted from
an anonymous genomic contig, accession no. AL590151 (Sanger
FIGURE 2. Identification of the 7G6
antigen. (A) SDS-PAGE (10% poly-
acrylamide gel) followed by Western
blot of hypotonic human macula ex-
tract probed with mAb 7G6. The
membrane fraction was separated
from soluble proteins by ultracentrif-
ugation. The antigen was detected by
Western blot with 7G6 antibody. HB,
homogenate supernatant boiled; HU,
homogenate supernatant unboiled.
HP, homogenate pellet. (B) Immuno-
precipitation of antigen with mAb
7G6. The human macular crude ex-
tract obtained after ultracentrifuga-
tion was incubated with mAb 7G6
and protein G-coupled agarose. The
immunoprecipitate was analyzed by
SDS-PAGE. Arrow 1: IgG; arrow 2:
7G6 antigen. (C) Sequence determi-
nation of proteolytic peptides. The
peptide sequences unambiguously
match human cone arrestin. Peptide
sequences identified by Edman deg-
radation are underscored in blue,
and sequences identified by LC-
MS/MS are underscored in red. (D)
Western blot of bacterial recombi-
nant His-tagged human cone arrestin.
The bacterial pellet was lysed by son-
ication, and the soluble fraction was
probed with mAb 7G6. The immu-
nopositive antigen has a mobility of
50 kDa (arrow). (E) Competition
of mAb 7G6 with recombinant hu-
man cone arrestin. Left: human
4-month-old retinoblastoma retina
was probed with mAb 7G6 (1:100
dilution) overnight at 4°C. Right:
mAb 7G6 preabsorbed 6 hours with
15 g recombinant cone arrestin and
incubated overnight as in (A). Re-
combinant cone arrestin abolished
the native cone arrestin.
2862 Zhang et al IOVS, July 2003, Vol. 44, No. 7
FIGURE 3. Redistribution of cone ar-
restin in bovine cones, depending on
the light history. (A) Dark-adapted
bovine retinas. mAb 7G6 labeled the
synaptic pedicles, the somata, and
the inner and outer segments of the
cones. In the dark, the bulk of cone
arrestin was concentrated in the my-
oid region, the place of biosynthesis.
(B) Fully bleached bovine retina. The
bulk of cone arrestin was in the outer
segments, where phototransduction
occurs. The confocal images shown
are representative of experiments
performed with three different pairs
of eyes in the fall of 2001 and the
spring and summer of 2002.
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Centre, Hinxton Hall, UK); bov_Arr, bovine arrestin (accession
AAA30377); mus_Arr, mouse arrestin (accession no. NP_03314);
and hum_arr, human arrestin (accession no. 14737493). The
sequences were aligned with Clustal W (http://www.ebi.ac.uk/
clustalw/ provided in the public domain by the European Bioin-
formatics Institute, European Molecular Biology Laboratory, Hei-
delberg, Germany) and shaded with Boxshade (http://www.
ch.embnet.org/software/box_form.html/ provided in the public
domain by the Ludwig Institute of Cancer Research and the ISREC
Bioinformatics Group, Swiss Institute of Bioinformatics, Basel,
Switzerland).
Identification of the mAb 7G6 Epitope
To determine the epitope for 7G6 in human cone arrestin, we
systematically deleted the divergent regions, starting at the
C-terminal end, and assayed the truncation mutants for 7G6
immunoreactivity by Western blot analysis. Because human
and bovine cArr C termini are nearly identical and distinct from
the C termini of other cone arrestins, we suspected that the
epitope for mAb 7G6 may be located there, particularly be-
cause this region carries a number of charged residues and is
predicted to be antigenic by exposure on the surface of the
molecule (see Fig. 2 in Ref. 28). However, C-terminal deletion
mutants in which 23 and 35 C-terminal residues were removed
by site directed mutagenesis (4 and 5 in Fig. 5), were still
immunoreactive (Fig. 6, bottom). We then deleted residues
188-388 (3 in Fig. 5), 169-388 (2), and 98-388 (1) in cone
arrestin, and only deletion mutant 1 was shown to be immu-
nonegative with 7G6 (Fig. 6, top). Inspection of the sequence
alignment narrowed the antigenic determinant for 7G6 in hu-
man cArr to a short region in the N-domain. This region is
nearly identical in human and bovine cArr, but divergent in
rodent and other vertebrate cone arrestin sequences. We con-
clude that the epitope recognized by mAb 7G6 is located in
this divergent loop exposed to the surface of cone arrestin.
DISCUSSION
We have shown that a widely used immunocytochemical cone
marker recognizes cone arrestin, a regulatory component of
the cone cascade. Using deletion mutants of human cone
arrestin, we have shown that the antigenic determinant is
located in a divergent surface-exposed loop in the N-domain of
cone arrestin, assuming that cone arrestin has a three-dimen-
sional structure that is very similar to rod arrestin. The high
sequence conservation between rod and cone arrestins (Fig. 5)
largely justifies this conclusion. The proposed antigenic deter-
minant is nearly identical in bovine and human cone arrestin,
but is divergent in other cone arrestin sequences, consistent
with the presence of the 7G6 epitope only in human, primate,
and bovine retinas.
The function of arrestins consists of desensitizing a G-pro-
tein–coupled receptor (in photoreceptors, the rod and cone
pigments). Similar to rod arrestin (for review, see Ref. 30), the
function of cone arrestin is presumed to consist of interacting
with phosphorylated cone visual pigments and downregulating
or quenching the cone cascade, thus contributing to desensi-
tization and light adaptation.31 Regeneration of the rod and
cone visual pigments is thought to require phosphorylation by
a rhodopsin kinase termed GRK132 or by both GRK1 and
GRK7.33,34
Recombinant cone arrestins show little affinity for phos-
phorylated or nonphosphorylated rhodopsin.35,36 In vitro
work with recombinant mouse cone arrestin suggests that it
interacts with chicken cone pigments in a light- and phospho-
rylation-dependent manner.18 Based on crystal structure data
of rod arrestin, it is assumed that the receptor’s C-terminal tail
FIGURE 4. Gene structures of vertebrate cone arrestins. The exon-intron arrangements were determined from publicly available anonymous
contigs deposited in GenBank: human cArr contig, AL357752, containing a complete human cArr DNA sequence on chromosome X (q13.2-21.1;
length, 178,868 bp); mouse cArr contig AC091784, length 215,734 bp; rat cArr contig, AC095218, 73 unordered pieces (length, 183,219 bp); and
zebrafish cArr contig AL590151, in ordered pieces, length 136,930 bp. Several independent zebrafish ESTs, shown below the gene diagram, are
consistent with the predicted RNA/amino acid sequences of zebrafish cArr. Three ESTs extend presumably to the transcription start point at the
beginning of the 5UTR exon. Two 3UTR ESTs carry poly(A) tails. A composite zebrafish cArr mRNA sequence from the transcription start point
to the beginning of the poly(A) tail has been deposited in GenBank. Black boxes: coding exons; gray boxes: noncoding exons.
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containing the phosphorylation sites acts as a switch to induce
a conformational change in arrestins that enables binding to
the receptor.28,37 A similar model for arrestin/receptor inter-
action was proposed in solution on the basis of small angle
x-ray scattering experiments.38 Rod arrestin’s binding to the
receptor is sensitive to alternative splicing and missense muta-
FIGURE 5. Determination of the 7G6 epitope. Amino acid sequence alignment of rod (Arr) and cone arrestins (cArr). Black triangles, above and
below the human and zebrafish sequences, respectively, indicate positions of introns in the gene sequences. Black arrows: truncated areas in
mutants of human cone arrestin (1 – 5). Shaded bars 1 to 4: divergent areas. The three-dimensional structure of rod arrestin is indicated above
the bovine rod arrestin sequence. Large arrows,  sheets; cylinders, -helices.
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tions. A bovine arrestin splice variant (p44) without the C-
terminal peptide encoded by the last exon can bind to unphos-
phorylated rhodopsin.39 Arrestin mutant R175Q binds to
activated phosphorylated and unphosphorylated rhodopsin,
and Arr (R175E) binds to bleached rhodopsin from which the
C-terminal phosphorylation sites have been removed.40 Other
residues (D30, R175, D296, and D303 based on the bovine
arrestin sequence) have been identified that enable binding to
nonphosphorylated rhodopsin.37 The mutant arrestins are pre-
sumably switched into the active conformation in the absence
of rhodopsin phosphorylation. All these residues are well con-
served in cone arrestins (Fig. 5, asterisks), suggesting a similar
functional role of cone arrestin in quenching the cone cascade.
The uniform distribution of cone arrestin throughout the cell
indicates that it diffuses freely in the cytoplasm. We cannot
exclude that cone arrestin may have additional functions un-
related to quenching the cone cascade.
Malfunctioning in receptor phosphorylation (in which
there is no quenching of the cascade) has been linked to
cardiac disease in transgenic animal models41 and to congenital
stationary night blindness in humans.42,43 Patients with natu-
rally occurring mutations in rod arrestin have Oguchi disease,
a form of inherited stationary night blindness.44 In arrestin-
knockout mice, photoresponses are prolonged, consistent
with the absence of quenching.45 In addition, it has been
demonstrated that excessive light can cause rod cell death in
pigmented rod arrestin-knockout mice.46–48 In human, the
cArr gene is located on the long arm of the X chromosome near
the centromere (Xcen-Xq22).25 Because cone arrestin’s pre-
sumed quenching capacity must be vital for proper cone func-
tioning, its gene is considered a candidate gene for cone dys-
trophies or macular degenerations. No defects in the cone
arrestin gene have so far been linked to human retinal dystro-
phies. In preliminary experiments, we screened three patients
with X-linked cone disease for disease-causing mutations, but
no mutation was identified (results not shown).
The movement of arrestins and transducin subunits in rods
and cones is an interesting phenomenon representing a novel
mechanism of light–dark adaptation. In light, arrestins accu-
mulate in the outer segments to quench the phototransduction
cascades. Rod transducin subunits, in contrast, move in the
opposite direction24,49,50 to desensitize the cascade. The traffic
from the inner to the outer segments must pass through a
narrow interconnecting cilium in both rods and cones. In
Kif3A conditional knockout mice, arrestin and rhodopsin trans-
port, but not transducin transport, was shown to be dependent
on kinesin II, a ubiquitous molecular motor51 present in the
cilium. Unresolved questions include the mechanisms that trig-
ger the relocalization of these components and exactly which
motors and motor subunits are involved in translocation.
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